Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-21-047740
Filing Date
2021-09-13
Accepted
2021-09-13 18:01:19
Documents
2
Period of Report
2021-09-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 4  
1 OWNERSHIP DOCUMENT ownership.xml 4 4088
2 POWER OF ATTORNEY ea147324ex24_celularity.htm EX-24 7986
  Complete submission text file 0001213900-21-047740.txt   13581
Mailing Address C/O TRIMARAN CAPITAL PARTNERS 622 THIRD AVENUE, 35TH FLOOR NEW YORK NY 10017
Business Address
Kehler Dean C (Reporting) CIK: 0001322745 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38914 | Film No.: 211250657

Mailing Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019 2126163700
Celularity Inc (Issuer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations